NCT05162833View on ClinicalTrials.gov

Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms

NACompletedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

February 20, 2022

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions

Overactive Bladder

Interventions

DEVICE

TheraNova Neuromodulation Device

TENS device

Trial Locations (2)

94305

Stanford University Medical Center, Stanford

95817

UC Davis Health, Sacramento

All Listed Sponsors

lead

Theranova, L.L.C.

INDUSTRY